Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to Pediatric Review Voucher (PRV); H.R. 10359, Priority for Pediatric Cures Act
Biosimilars Access and Affordability Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Monitor issues related to 340b;
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| SNP ALLIANCE INC |
| 59 |
| 2009–2024 |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | 54 | 2007–2023 |
| MERCK & CO., INC. | 48 | 2015–2026 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | 46 | 2014–2024 |
| AMERICAN MEDICAL ASSOCIATION | 45 | 2016–2026 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSN (FOR ACCESS TO MEDICAL IMAGING COALITION) | 44 | 2007–2018 |
| PEDIATRIX MEDICAL GROUP, INC. | 39 | 2016–2025 |
| EXPRESS SCRIPTS INC | 36 | 2005–2015 |
| KIDNEY CARE PARTNERS | 33 | 2015–2024 |
| OMEROS CORPORATION | 33 | 2018–2026 |
| ILLUMINA, INC. | 32 | 2019–2026 |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 30 | 2016–2024 |
| INCYTE CORPORATION | 29 | 2019–2026 |
| GRAIL, Inc. | 27 | 2020–2026 |
| MODERNA, INC. | 27 | 2020–2026 |
| AETNA | 26 | 2002–2012 |
| AMEDISYS HOME HEALTH AND HOSPICE CARE | 26 | 2018–2024 |
| GENENTECH USA, INC. | 24 | 2021–2026 |
| SAGE THERAPEUTICS, INC. | 24 | 2019–2024 |
| TRAVELERS COMPANIES INC | 24 | 2007–2012 |
| EDWARDS LIFESCIENCES LLC | 21 | 2021–2026 |
| AMERICAN BEVERAGE ASSOCIATION | 17 | 2022–2026 |
| KIDNEY CARE COUNCIL | 17 | 2015–2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | 15 | 2023–2026 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 14 | 2015–2018 |
| HELP AT HOME | 14 | 2023–2026 |
| NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION | 14 | 2015–2019 |
| CUBIST PHARMACEUTICALS, INC. | 13 | 2012–2014 |
| INDEPENDENT INSURANCE AGENTS & BROKERS OF AMERICA, INC. | 13 | 2013–2016 |
| MATRIX MEDICAL NETWORK | 13 | 2021–2023 |
| SIEMENS MEDICAL SOLUTIONS USA, INC | 13 | 2023–2026 |
| ZELIS HEALTHCARE CORP. | 13 | 2021–2024 |
| JPMORGAN CHASE HOLDINGS LLC | 12 | 2020–2025 |
| RICHIE'S SPECIALTY PHARMACY | 12 | 2013–2015 |
| MASSACHUSETTS 2020 | 11 | 2008–2010 |
| BRAVO HEALTH, INC. | 10 | 2008–2010 |
| GAINWELL TECHNOLOGIES | 10 | 2020–2022 |
| HOSPICE ACTION NETWORK | 10 | 2014–2016 |
| IOVANCE BIOTHERAPEUTICS, INC. | 9 | 2020–2022 |
| OMAHA ZOO FOUNDATION | 9 | 2008–2009 |
| AIMMUNE THERAPEUTICS | 8 | 2019–2020 |
| ALLIANCE FOR REGENERATIVE MEDICINE | 8 | 2023–2025 |
| CENTER FOR TECHNOLOGY COMMERCIALIZATION | 8 | 2008–2010 |
| DISTRICT OF COLUMBIA HOSPITAL ASSOCIATION | 8 | 2025–2026 |
| NATIONAL ALLIANCE FOR CARE AT HOME | 8 | 2025–2026 |
| NORTHWEST AIRLINES | 8 | 2005–2008 |
| ORACLE CORPORATION | 8 | 2022–2026 |
| UNITED PARCEL SERVICE (UPS) | 8 | 2010–2012 |
| BIOVERATIV INC. | 7 | 2017–2018 |
| FREDDIE MAC | 7 | 2006–2008 |
| UNIVERSAL AMERICAN FINANCIAL SERVICES (FOR COLLABORATIVE HEALTH SYSTEMS) | 7 | 2015–2016 |
| CITIGROUP | 6 | 2005–2008 |
| MARYLAND HOSPITAL ASSOCIATION | 6 | 2025–2026 |
| MOMENTA PHARMACEUTICALS, INC. | 6 | 2013–2014 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC | 6 | 2021–2022 |
| COALITION TO STRENGTHEN THE FUTURE OF MOLECULAR DIAGNOSTICS | 5 | 2013 |
| FINANCIAL SERVICES ROUNDTABLE | 5 | 2007–2008 |
| HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | 5 | 2020–2021 |
| PARTNERSHIP FOR MEDICAID HOME-BASED CARE (PMHC) | 5 | 2025–2026 |
| BRISTOL-MYERS SQUIBB COMPANY | 4 | 2026 |
| GROUP HEALTH COOPERATIVE | 4 | 2014–2015 |
| KARUNA THERAPEUTICS, INC. | 4 | 2023–2024 |
| MEDICAL INFORMATION TECHNOLOGY, INC. (MEDITECH) | 4 | 2026 |
| ROUTE 66 VENTURES, LLC | 4 | 2009 |
| TESARO, INC. | 4 | 2018–2019 |
| AIM EDUCATION, INC. | 3 | 2009 |
| AMGEN, INC. | 3 | 2026 |
| EPIX PHARMACEUTICALS | 3 | 2006–2007 |
| GINGER.IO, INC. | 3 | 2021 |
| HEMP INDUSTRY & FARMERS OF AMERICA (HIFA) | 3 | 2025–2026 |
| HOUSE RX, INC. | 3 | 2025 |
| NELNET INC | 3 | 2008–2013 |
| ORGANIC VOICES ACTION FUND | 3 | 2015 |
| SIMPLIFED, INC. | 3 | 2022 |
| STEMEXPRESS, LLC | 3 | 2020–2021 |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | 3 | 2026 |
| TOBACCO FREE KIDS ACTION FUND | 3 | 2022 |
| VIROPHARMA INCORPORATED | 3 | 2012 |
| VISITING NURSE SERVICE OF NEW YORK | 3 | 2014 |
| ANTHROPIC, PBC | 2 | 2026 |
| COMPASS PATHWAYS, INC. | 2 | 2026 |
| DEWEY SQUARE GROUP ON BEHALF OF BIRD RIDES, INC. | 2 | 2022 |
| LETSGETCHECKED INC. | 2 | 2023 |
| MILLENNIUM HEALTH LLC | 2 | 2015 |
| SCHOLASTIC INC | 2 | 2014 |
| THE METROHEALTH SYSTEM | 2 | 2022 |
| AGRICULTURAL DRONE INITIATIVE (INFORMAL COALITION) | 1 | 2026 |
| AMERICAN HEALTHY ALTERNATIVES ASSOCIATION (AHAA) | 1 | 2026 |
| APOLLO GLOBAL MANAGEMENT, INC. | 1 | 2026 |
| EXXON MOBIL CORPORATION | 1 | 2023 |
| OAK STREET HEALTH MSO, LLC | 1 | 2021 |
| THE NONPROFIT ALLIANCE | 1 | 2022 |
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Maintaining Investments in New Innovation Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Maintaining Investments in New Innovation Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Maintaining Investments in New Innovation Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; H.R. 8163/S. 5180, Provider Reimbursement Stability Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Protecting Patient Access to Cancer and Complex Therapies Act
Client: MERCK & CO. INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: MERCK & CO. INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Protecting Patient Access to Cancer and Complex Therapies Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: AVENUE SOLUTIONS
Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)
Protecting Patient Access to Cancer and Complex Therapies Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Protecting Patient Access to Cancer and Complex Therapies Act
Client: AMGEN, INC. · Firm: AVENUE SOLUTIONS
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: AVENUE SOLUTIONS
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Protecting Patient Access to Cancer and Complex Therapies Act
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: AVENUE SOLUTIONS
Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA); Issues related to Most Favored Nation (MFN)
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act
Protecting Patient Access to Cancer and Complex Therapies Act
Client: AMGEN, INC. · Firm: AVENUE SOLUTIONS
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related To S. 5459, The Biosimilar Access and Affordability Act; Issues related to Senate Finance Dear Colleague process
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC. · Firm: AVENUE SOLUTIONS
Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related To S. 5459, The Biosimilar Access and Affordability Act; Issues related to Senate Finance Dear Colleague process
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Patients Deserve Price Tags Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Patients Deserve Price Tags Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Patients Deserve Price Tags Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Patients Deserve Price Tags Act
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Patients Deserve Price Tags Act
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Patients Deserve Price Tags Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Genomic Answers for Children’s Health Act of 2026
Client: ILLUMINA, INC. · Firm: AVENUE SOLUTIONS
Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026
Genomic Answers for Children’s Health Act of 2026
Client: ILLUMINA, INC. · Firm: AVENUE SOLUTIONS
Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026
Provider Reimbursement Stability Act of 2026
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; H.R. 8163/S. 5180, Provider Reimbursement Stability Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Provider Reimbursement Stability Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act
Medicare Advantage Improvement Act of 2026
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: ILLUMINA, INC. · Firm: AVENUE SOLUTIONS
H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: GRAIL, INC. · Firm: AVENUE SOLUTIONS
H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; H.R. 8163/S. 5180, Provider Reimbursement Stability Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN MEDICAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Protecting Seniors and Stopping Fraudsters Act
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Protecting Seniors and Stopping Fraudsters Act
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Lower Costs, More Transparency Act of 2026
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Lower Costs, More Transparency Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Lower Costs, More Transparency Act of 2026
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Lower Costs, More Transparency Act of 2026
Client: UNITEDHEALTH GROUP INC · Firm: AVENUE SOLUTIONS
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Lower Costs, More Transparency Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Lower Costs, More Transparency Act of 2026
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Lower Costs, More Transparency Act of 2026
Client: UNITEDHEALTH GROUP INC · Firm: AVENUE SOLUTIONS
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Lower Costs, More Transparency Act of 2026
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act
Tax Exempt Hospital Transparency Act
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Tax Exempt Hospital Transparency Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Tax Exempt Hospital Transparency Act
Client: UNITEDHEALTH GROUP INC · Firm: AVENUE SOLUTIONS
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Tax Exempt Hospital Transparency Act
Client: BLUE CROSS BLUE SHIELD ASSOCIATION · Firm: AVENUE SOLUTIONS
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Tax Exempt Hospital Transparency Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Tax Exempt Hospital Transparency Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Tax Exempt Hospital Transparency Act
Client: UNITEDHEALTH GROUP INC · Firm: AVENUE SOLUTIONS
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Tax Exempt Hospital Transparency Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC. · Firm: AVENUE SOLUTIONS
Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related To S. 5459, The Biosimilar Access and Affordability Act; Issues related to Senate Finance Dear Colleague process
Patients Deserve Price Tags Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Patients Deserve Price Tags Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Patients Deserve Price Tags Act
Client: MARYLAND HOSPITAL ASSOCIATION · Firm: AVENUE SOLUTIONS
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE (PMHC) via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to Medicaid Home and Community-Based Services (HCBS); Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OMEROS CORPORATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to Pediatric Review Voucher (PRV); H.R. 10359, Priority for Pediatric Cures Act
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · third_quarter · Q3
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's approval of Moderna's flu vaccine; Issues related to Messenger RNA (mRNA) therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO. INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to vaccines; Issues related to 340b
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL INFORMATION TECHNOLOGY, INC. (MEDITECH) via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to electronic health records, including TEFCA, HTI-5, interoperability standards and rural health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARYLAND HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to Senate Finance Dear Colleague process
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing, including orphan drugs
INCYTE CORPORATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to 340B
Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process; Education around access to innovative therapies in dermatology; Issues related to the Orphan Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); Issues related to Senate Finance Dear Colleague process
GRAIL, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to multi-cancer early detection screening; Issues related to P.L. 119-75 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to 340b drug pricing program
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISTRICT OF COLUMBIA HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to DC Hospitals and Medicaid formula; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Issues related to DC taxes
COMPASS PATHWAYS, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to innovative treatment for mental health and PTSD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to prescription drugs, including 340B program
Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA); Issues related to Most Favored Nation (MFN)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOLLO GLOBAL MANAGEMENT, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to hospital management.
AMGEN, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related to Senate Finance Dear Colleague process; H.R. 10628/S. 5571, Biosimilars Access and Affordability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; H.R. 8163/S. 5180, Provider Reimbursement Stability Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to health workforce, including H1B visa and student loan reform; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BEVERAGE ASSOCIATION via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to health and nutrition
OMEROS CORPORATION via AVENUE SOLUTIONS
2026 · third_quarter · RA
Issues related to Pediatric Review Voucher (PRV)
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Monitor issues related to 340b;
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to drug pricing and reimbursement for prescription drugs
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE (PMHC) via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Medicaid Home and Community-Based Services (HCBS); Issues related to Senate Finance Dear Colleague process
ORACLE CORPORATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to data centers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · second_quarter · Q2
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's delay in reviewing Moderna's flu vaccine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO. INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Issues related to vaccines; Issues related to 340b
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL INFORMATION TECHNOLOGY, INC. (MEDITECH) via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to electronic health records, including TEFCA, HTI-5, interoperability standards and rural health; Issues related to Senator Wyden's letter to Electronic Health Record (EHR) companies and the adoption of privacy measures to protect patient data
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARYLAND HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to Senate Finance Dear Colleague process
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2026 · second_quarter · Q2
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing, including orphan drugs
INCYTE CORPORATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE)); Issues related to Senate Finance Dear Colleague process
Issues related to 340b
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
General trade issues
Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to multi-cancer early detection screening; Issues related to P.L. 119-75 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to 340b drug pricing program
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISTRICT OF COLUMBIA HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to DC Hospitals and Medicaid formula; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
BRISTOL-MYERS SQUIBB COMPANY via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to prescription drugs
Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Healthcare affordability platform; Issues related to Senate Finance Dear Colleague process; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTHROPIC, PBC via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues relating to safety, development and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 5526/S. 1954, Biosimilar Red Tape Elimination Act; Issues related To S. 5459, The Biosimilar Access and Affordability Act; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to health workforce, including H1B visa and student loan reform; Issues related to surprise medical billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BEVERAGE ASSOCIATION via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to health and nutrition
AGRICULTURAL DRONE INITIATIVE (INFORMAL COALITION) via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to drone competitiveness; Issues related to foreign-made drones
Issues related to drone competitiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA, INC. via AVENUE SOLUTIONS
2026 · second_quarter · RR
Issues related to drug pricing and reimbursement for prescription drugs.
COMPASS PATHWAYS, INC. via AVENUE SOLUTIONS
2026 · second_quarter · RR
Issues related to innovative treatment for mental health and PTSD.
AMERICAN HEALTHY ALTERNATIVES ASSOCIATION (AHAA) via AVENUE SOLUTIONS
2026 · second_quarter · RR
Issues related to hemp
AMGEN, INC. via AVENUE SOLUTIONS
2026 · second_quarter · RR
Issues related to drug pricing and reimbursement for prescription drugs.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE (PMHC) via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Medicaid Home and Community-Based Services (HCBS); Issues related to Senate Finance Dear Colleague process
ORACLE CORPORATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to data centers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's delay in reviewing Moderna's flu vaccine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO. INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to the implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process
Issues related to vaccines; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL INFORMATION TECHNOLOGY, INC. (MEDITECH) via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to electronic health records; Issues related to Senator Wyden's letter to Electronic Health Record (EHR) companies and the adoption of privacy measures to protect patient data
Filing targets: SENATE
MARYLAND HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to health workforce, including H1B visa and student loan reform
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2026 · first_quarter · Q1
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing, including orphan drugs; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE))
Issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMP INDUSTRY & FARMERS OF AMERICA (HIFA) via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to hemp.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); Issues related to Senate Finance Dear Colleague process
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
GRAIL, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Coverage of multi-cancer early detection tests; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Support for H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1672, Maintaining Investments in New Innovation Act; Issues related to Senate Finance Dear Colleague process
Issues related to 340b drug pricing program; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISTRICT OF COLUMBIA HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to DC Hospitals and Medicaid formula; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to prescription drugs
Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process
BLUE CROSS BLUE SHIELD ASSOCIATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to Medicare Advantage; Issues related to site neutral payments; Issues related to PBM reforms; S. 1105, No UPCODE Act
Healthcare affordability platform; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; Issues related to Provider Reimbursement Stability Act and Merit Based Incentive Payments System (MIPS) reform; Issues related to Senate Finance Dear Colleague process
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to health workforce, including H1B visa and student loan reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BEVERAGE ASSOCIATION via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Issues related to health and nutrition
BRISTOL-MYERS SQUIBB COMPANY via AVENUE SOLUTIONS
2026 · first_quarter · RR
Issues related to prescription drugs.
Issues related to prescription drugs.
MEDICAL INFORMATION TECHNOLOGY, INC. (MEDITECH) via AVENUE SOLUTIONS
2026 · first_quarter · RR
Issues related to electronic medical records.
ANTHROPIC, PBC via AVENUE SOLUTIONS
2026 · first_quarter · RR
Issues related to AI.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Monitor issues related to 340b; Expiring healthcare extenders
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues relating to Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Expiring healthcare extenders; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act
Issues related to expiring healthcare extenders; Expiration of the ACA's Enhanced Premium Tax Credits (EPTCs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; Monitor expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR MEDICAID HOME-BASED CARE (PMHC) via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to Medicaid Home and Community-Based Services (HCBS)
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Expiring healthcare extenders; Expiring telehealth extender
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO. INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to vaccines; Expiring healthcare extenders
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to the implementation of the Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARYLAND HOSPITAL ASSOCIATION via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Expiring healthcare extenders; Issues related to CMS regulations and effect on Maryland hospitals; Issues related to the expiration of the ACA's APTC (Advanced Premium Tax Credit)
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Issues related to 340b; Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing; Expiring healthcare extenders; Issues related to BIOSECURE
Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to 340b; Expiring healthcare extenders; Issues related to Priority Review Voucher (PRV) program
Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to NIH grant funding for public health; Issues related to genomic sequencing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOUSE RX, INC. via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025
Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE